Medisca's Hair Care Compounding Solutions

Download in electronic PDF format for $25

Search the Complete Journal Archives

Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension

Author(s):  Haase Mark R, Khan Mansoor A, Bonilla Jeremiah

Issue:  Nov/Dec 2003 - Compounding for Investigational Studies
View All Articles in Issue

Abstract:  The short-term stability of two different concentrations of extemporaneously compounded tiagabine suspensions was studied. Six bottles each of 6-mg/mL and 2-mg/mL suspensions were compounded using commercially available 16-mg tiagabine tablets in a 1:1 mixture of Ora-Sweet and Ora-Plus. For each concentration, three bottles were stored in the dark in a stability chamber at 23 to 25°C, and three were stored in the dark in a refrigerator at 3 to 5°C, for 61 days. The stability of tiagabine in each of the concentrations and environmental conditions was determined after preparation and at 7, 14, 28, 42 and 61 days by means of a high-performance liquid chromatographic method, which involved a reversephase column, a gradient mobile phase containing acetonitrile and aqueous phosphoric acid at a flow rate of 2.75 mL/minute. Detection was carried out by an ultraviolet spectrophotometer at 254 nm. The drug tiagabine, the internal standard (propylparaben) and degradant eluted at 8.4, 8.6 and 9.9 minutes, respectively. The high-performance liquid chromatrographic validation involved limit of detection, limit of quantitation, accuracy and precision and interday and intraday variation. There was no appearance of degradation products in either concentration at any time. The suspensions stored at 23 to 25°C became slightly discolored after day 30, turning slightly gray from blue. However, this change could not be attributed to tiagabine degradation. The refrigerated suspensions were found to be stable (retention of 90% potency) up to 40 days. The 6-mg/mL suspensions were stable up to the study period of 61 days; however, the 2-mg/mL suspension at 3 to 5°C showed a potency of 87.7% on day 61 of the study.

Extemporaneously compounded liquid oral preparations of tiagabine 6 mg/mL in a 1:1 mixture of Ora-Plus and Ora-Sweet were stable for 61 days at 23 to 25°C and 3 to 5°C. The extemporaneously compounded liquid oral preparations of tiagabine 2 mg/mL in a 1:1 mixture of Ora-Plus and Ora-Sweet were stable for 61 days at 23 to 25°C and for 40 days at 3 to 5°C.

Related Keywords: Bonilla, BS, Jeremiah, Haase, PharmD, BCPS, Mark R., Kahn, RPh, PhD, Mansoor A., Tiagabine, stability of suspension of


Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension Haase Mark R, Khan Mansoor A, Bonilla Jeremiah Nov/Dec 2003 485-489 Buy
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George Jan/Feb 2009 14-18 Buy
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Anderson Collin R, Halford Zachery, MacKay Mark Jul/Aug 2015 344-347 Buy
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok Jan/Feb 2006 74-78 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N Sep/Oct 2003 389-393 Buy
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Trissel Lawrence A, Zhang Yanping, Koontz Susannah E Sep/Oct 2006 396-399 Buy
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Ford Stephen M, Kloesel Lawson G, Grabenstein John D Mar/Apr 2007 164-176 Buy
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Voudrie Mark A, Alexander Bridget, Allen D Brett May/Jun 2011 255-258 Buy
Stability of Gabapentin in SyrSpend SF Sorenson Bridget, Voudrie Mark A II, Gehrig Dan Jul/Aug 2012 347-349 Buy